RxDoctor Payments Data

Thomas Evans, MD

Interventional Pain Medicine · Vail, CONPI 1083643654

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by SPR Therapeutics, Inc at 24.6% of the total. Reporting peaked in 2022 at $370 and has fallen 76.0% since, to $89 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in CO, where the typical reported total is $1,539.

$1,363in general payments, 2019–2025

Across 35 payments — averaging $38.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SPR Therapeutics, Inc$335
  • AbbVie$294
  • MML US, Inc.$164
  • Arthrex$119
  • Boston Scientific$107
  • Stratus Medical, LLC$80
  • plus $264 from 8 others

What the payments were for

  • Food & beverage$1,363100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
SPR Therapeutics, Inc4$335
AbbVie(2 entities)13$294
MML US, Inc.1$164
Arthrex1$119
Boston Scientific3$107
Stratus Medical, LLC3$80
Zimmer Biomet1$58
Abbott2$51
Medtronic(2 entities)2$48
Hydrocision, Inc.1$29
Nevro Corp.1$25
Vertos Medical, Inc.1$24
Bioventus LLC1$16
Fidia Pharma USA Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,363 in reported general payments places this provider in the 45th percentile of 25 interventional pain medicine providers in Colorado.

See all interventional pain medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$99,082
Medicare patients
282
Services billed
1,593

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Vail

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →